Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 11 May 2018
At a glance
- Drugs Triamcinolone (Primary)
- Indications Panuveitis; Uveitis
- Focus Therapeutic Use
- Acronyms MAGNOLIA
- Sponsors Clearside Biomedical
- 30 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Aug 2018.
- 09 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Aug 2018.